secwatch.observer — SEC 8-K summary
======================================

Issuer:     Syra Health Corp (SYRA)
CIK:        0001922335
Form:       8-K
Filed at:   2026-08-11T12:37:15+00:00
Accession:  0001493152-26-036995
Event type: earnings
Sentiment:  positive
Materiality: 0.70
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Syra Health posts Q2 2026 profit of $250K, revenue up 23% YoY to $2.4M
----------------------------------------------------------------------

- Q2 2026 net income $250,242 vs net loss $(63,596) in Q2 2025; second consecutive profitable quarter.
- Revenue grew 23% YoY to $2.4M; gross margin expanded to 44.5%, a company record, up from 38.7%.
- EPS $0.02 vs $(0.01) loss; EBITDA turned positive at $253,200 vs $(53,760) in Q2 2025.
- Healthcare workforce revenue jumped 87% YoY to $678,113; population health rose 8% to $1.7M.
- Anticipates CMS ACCESS Model approval with HealthSync as potential 10-year revenue; cash $2.1M, no long-term debt.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1922335/000149315226036995/0001493152-26-036995-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1922335/000149315226036995/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-036995

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer